Treatment
Treatment clinical trials
We’re tracking 8,322 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07065344Recruiting
A study of patients with DLBCL in the Middle East and Africa
This study looks at patients with diffuse large B-cell lymphoma (DLBCL) in the Middle East and Africa. It aims to understand how the disease is treated, what treatments are available, and how patients access newer therapies. You simply continue your regular care and the study team collects information.
Al MansurahAges Any age - NCT07065214Recruiting
Argon plasma vs. standard surgery for ovarian endometrioma
This study compares two ways to treat ovarian endometriomas during surgery: the standard method (removing the cyst) versus a newer technique using argon plasma (a gas that burns away tissue without cutting). The goal is to see which approach works better and helps preserve your ovaries.
Tübingen, GermanyAges 18–40 - NCT07069712RecruitingPhase 2
New drug combinations before and after surgery for stomach or esophageal cancer
This study tests new drug combinations given before and after surgery for people with stomach or gastroesophageal cancer that can be removed but is locally advanced (has grown into nearby tissue). The goal is to see if these combinations can shrink the tumor and improve outcomes.
Newark, DelawareAges 18 years+ - NCT06982989Recruiting
Wearable light therapy for pelvic pain
This study tests a wearable device that uses LED light to treat pelvic pain. It may be an option for people who want a non-medicine approach to managing their pain.
Beijing, Beijing MunicipalityAges 18–35 - NCT05333328RecruitingPhase 4
Test of ovarian function suppression for low-risk premenopausal node+ breast cancer
This trial studies whether ovarian function suppression (a treatment that lowers hormone production from the ovaries) helps women with hormone-receptor positive, HER2-negative breast cancer that has spread to lymph nodes, but who have a low-risk result on a genomic test. It may help reduce breast cancer recurrence while avoiding more intensive treatment for those who are lower risk.
Seoul, KoreaAges 20–50 - NCT06053255Recruiting
Testing a new device for low back pain from sacroiliitis
This trial tests a device called the Neurolyser XR to treat chronic low back pain caused by inflammation of the sacroiliac joint. It may help if you've had pain for over a year and other treatments haven't worked.
Charlottesville, VirginiaAges 18 years+ - NCT05635669Recruiting
Acupuncture for mild to moderate stress urine leaks
This trial studies whether an “optimized” acupuncture treatment can reduce urine leakage caused by stress, like coughing or laughing. It is mainly for adults with mild to moderate stress urinary incontinence who are medically able to receive acupuncture.
ShanghaiAges 40–75 - NCT05667948Recruiting
Testing targeted treatments for thymus cancer using tumor testing
This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07069127Recruiting
Home treatment for tooth sensitivity in celiac disease
This study tests a special toothpaste-like treatment for adults with celiac disease who have sensitive teeth and enamel problems. You apply it at home, and it may help reduce tooth pain and protect your teeth.
Pavia, LombardyAges 18 years+ - NCT07072247RecruitingPhase 1
RN1201 injection for hard-to-treat antibody-mediated blood disorders
This trial tests a new injection called RN1201 for people with antibody-mediated diseases, specifically two types of blood disorders: platelet transfusion refractoriness (PTR) and immune thrombocytopenia (ITP) that haven't responded to standard treatments. The goal is to see if RN1201 can help control these conditions.
Suzhou, JiangsuAges 16–65 - NCT07068893Recruiting
Wrist dislocation surgery with internal brace technique
This study looks at a surgical technique using four anchors and an internal brace to treat a type of wrist dislocation (perilunate). It may be an option if you've already had surgery for this injury and don't have broken wrist bones.
Orlando, FloridaAges 18–88 - NCT07071961RecruitingPhase 2
Treatment for colorectal cancer with signs of remaining disease after therapy
This trial tests a combination of two drugs, regorafenib and lorigerlimab, for people with colorectal cancer that has a positive blood test for cancer DNA after they have finished standard treatments. The goal is to see if this treatment can delay or prevent the cancer from coming back.
Houston, TexasAges 18 years+ - NCT07067385RecruitingPhase 1
Personalized mRNA vaccine for advanced GI cancers
This trial tests a personalized mRNA vaccine designed to teach your immune system to attack your specific tumor. It is for people with advanced gastrointestinal cancers who have exhausted other options.
Shanghai, SHAges 18 years+ - NCT07066527Recruiting
New foam vs. standard foam for head and neck vein malformations
This study tests a new type of foam (polylauric alcohol foam) compared to standard foam for treating venous malformations (clusters of abnormal veins) in the head and neck area. The goal is to see if the new foam works better and is just as safe.
Jinan, ShandongAges 14–60 - NCT07065409RecruitingPhase 1
Exosomes for Moyamoya disease treatment trial
This trial tests whether exosomes made from special stem cells can help people with Moyamoya disease who still have symptoms after surgery. It aims to improve blood flow to the brain and reduce future strokes.
Wuhan, HubeiAges 18–75 - NCT07071038RecruitingPhase 2
Switching medication to relieve side effects from aromatase inhibitors
This trial tests whether switching to a different aromatase inhibitor or using standard treatments works better for managing side effects in breast cancer survivors. It aims to help you stay on hormone therapy longer with fewer discomforts.
Lebanon, New HampshireAges 18 years+ - NCT07073430Recruiting
AI tool to help diagnose precancerous colon polyps
This trial tests an artificial intelligence system that helps doctors find and diagnose tubular adenomas (a type of precancerous polyp) during colonoscopy. It may improve early detection of colorectal cancer.
Wuhan, HubeiAges 18 years+ - NCT07074951Recruiting
Tonsillectomy and immune therapy for high-risk IgA kidney disease
This trial tests whether removing the tonsils (tonsillectomy) plus immune-suppressing therapy can help people with a high-risk form of IgA nephropathy, a kidney disease. It aims to slow down kidney damage and delay the need for dialysis.
Saint PetersburgAges 18–75 - NCT07074444Recruiting
Treating clonorchiasis with three different drugs
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
Nanning, GuangxiAges 18 years+ - NCT07065279Recruiting
JY231 injection for relapsed B-cell blood cancers
This trial tests a new treatment, JY231, for people with B-cell blood cancers that have come back or not responded to other treatments. It aims to see if this therapy can help when other options have stopped working.
Kunming, YunnanAges 2–75 - NCT07070765Recruiting
Study on dapagliflozin to protect the heart during breast cancer chemo
This trial tests if a heart-protecting drug called dapagliflozin can help prevent heart damage in breast cancer patients receiving a type of chemotherapy called anthracycline. It may be an option if you have low to medium heart risk factors.
Aberdeen, AberdeenshireAges 18–70 - NCT07069517Recruiting
Fast treatment for insomnia, nightmares, and PTSD
This study tests a combined program to help active-duty military and veterans with PTSD, insomnia, and nightmares. It aims to see if a short treatment can improve sleep and reduce PTSD symptoms without starting new medications or other therapies.
Kileen, TexasAges 18–65 - NCT07071493Enrolling by invitation
Light and nerve stimulation for alcohol cravings
This study tests if combining two gentle brain and nerve stimulation methods (light on the head and mild electrical pulses on the ear) can reduce alcohol cravings and change brain activity in people who drink but do not have alcohol use disorder. Participants will attend sessions for 5 weeks.
SeoulAges 19–40 - NCT07072234RecruitingPhase 1
CAR NK cell therapy for advanced clear cell kidney cancer
This trial tests a new type of immune cell therapy (CAR NK cells) that targets a protein called CD70 on kidney cancer cells. It's for people with advanced clear cell kidney cancer that hasn't responded to standard treatments.
Houston, TexasAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,322 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.